精彩内容近期,业内传出#第十一批集采 药品清单,或再有3个头孢类产品被盯上,涉及两款超10亿注射剂。前十批集采已累计有28个头孢类产品中标,涉及的19个品种2024年在中国公立医疗机构终端的合计市场规模比2018年缩水超过280亿元。2025年Q1头孢类产品再有超过10%的降幅,惊现“8连跌”,齐鲁制药近几年逆势飞涨,首次挺进TOP4集团。第十一批集采要来了!两款超10亿注射剂将洗牌#头孢类产品是...
Source Link精彩内容近期,业内传出#第十一批集采 药品清单,或再有3个头孢类产品被盯上,涉及两款超10亿注射剂。前十批集采已累计有28个头孢类产品中标,涉及的19个品种2024年在中国公立医疗机构终端的合计市场规模比2018年缩水超过280亿元。2025年Q1头孢类产品再有超过10%的降幅,惊现“8连跌”,齐鲁制药近几年逆势飞涨,首次挺进TOP4集团。第十一批集采要来了!两款超10亿注射剂将洗牌#头孢类产品是...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.